Movahed Mohammad Reza, Abhari Amir Parsa, Hashemzadeh Mehrtash
Department of Medicine, College of Medicine, University of Arizona, Phoenix, AZ 85004, USA.
Department of Medicine, Sarver Heart Center, University of Arizona, Tucson, AZ 85724, USA.
J Clin Med. 2024 Oct 2;13(19):5897. doi: 10.3390/jcm13195897.
The obesity paradox has been observed in patients with cardiovascular disease. The goal of this study was to evaluate whether obesity has a protective effect in patients presenting with an ST elevation myocardial infarction (STEMI). Using the large Nationwide Inpatient (NIS) sample database, we evaluated the mortality in patients with a STEMI based on weight categories. A total of 2,161,640 STEMI patients were found in the database over age 18. We found that overweight and obesity had the lowest mortality using univariate (overweight mortality of 5% vs. obesity mortality of 6.5% vs. 10.9% for normal weights) and multivariate analyses (overweight OR: 0.52, CI: 0.43-063; < 0.001 and obesity OR: 0.7, CI: 0.67-0.74; < 0.001), whereas cachexia was associated with the highest mortality in the univariate (cachexia 24.5%) and multivariate (OR: 2.28, CI: 2.13-2.44; < 0.001) analyses, followed by morbid obesity in the multivariate analysis (OR: 1.07, CI: 1.02-1.12; = 0.004). We observed a partial obesity paradox in patients with a STEMI showing that overweight have the best survival rates followed by obesity. Cachexia followed by morbid obesity had the lowest survival rates.
肥胖悖论已在心血管疾病患者中被观察到。本研究的目的是评估肥胖在ST段抬高型心肌梗死(STEMI)患者中是否具有保护作用。利用大型全国住院患者(NIS)样本数据库,我们根据体重类别评估了STEMI患者的死亡率。在该数据库中总共发现了2161640名年龄在18岁以上的STEMI患者。我们发现,在单因素分析(正常体重者死亡率为10.9%,超重者死亡率为5%,肥胖者死亡率为6.5%)和多因素分析(超重:比值比[OR]为0.52,95%置信区间[CI]为0.43 - 0.63;P < 0.001;肥胖:OR为0.7,CI为0.67 - 0.74;P < 0.001)中,超重和肥胖患者的死亡率最低,而恶病质在单因素分析(恶病质患者死亡率为24.5%)和多因素分析(OR为2.28,CI为2.13 - 2.44;P < 0.001)中与最高死亡率相关,其次是多因素分析中的病态肥胖(OR为1.07,CI为1.02 - 1.12;P = 0.004)。我们在STEMI患者中观察到部分肥胖悖论,即超重患者的生存率最佳,其次是肥胖患者。恶病质其次是病态肥胖患者的生存率最低。